Gene · 4591
NIH grants974
NIH grants whose papers are about the gene, through NIH's grant-paper links.
401 to 420 of 974
Download this page as JSON| Grant | Title | TRIM37 papers | Newest fiscal year |
|---|---|---|---|
| R01AI127774 | Flavivirus NS3-mediated Innate Immune Escape | 2 | 2020 |
| T32GM007618 | Medical Scientist Training Program | 2 | 2020 |
| UM1HG006542 | Baylor Johns Hopkins Center for Mendelian Genetics | 2 | 2020 |
| F30AI143401 | Harnessing the RNA-Cleaving Properties of CRISPR-Cas13a for Applications to HIV Detection and Latency | 1 | 2020 |
| F99CA245719 | Dissecting the molecular mechanism of heterochromatin misregulation at the nuclear periphery in cancer | 1 | 2020 |
| I01CX000512 | Early detection of lung cancer in Veterans | 1 | 2020 |
| I01RX000559 | Longitudinal Changes in Auditory Function Among Veterans with Diabetes | 1 | 2020 |
| K01AI122853 | Optimizing Care for HIV/HCV-Coinfected Patients in the New HCV Treatment Era | 1 | 2020 |
| K08CA208013 | Oncogenic programs driven by notch signaling in B-cell lymphoma | 1 | 2020 |
| K99AI147811 | The Vif-APOBEC Nexus | 1 | 2020 |
| P50CA098258 | MD Anderson Gynecologic SPORE for Uterine Cancers | 1 | 2020 |
| R01AI100887 | Immune repertoire and function in typical and atypical SCID | 1 | 2020 |
| R01CA180475 | KDM6A mutation as an epigenetic driver of multiple myeloma | 1 | 2020 |
| R01CA193520 | The Role of lncRNA MEG3 in Clinically Non-functioning Pituitary Adenomas | 1 | 2020 |
| R01CA207272 | Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia | 1 | 2020 |
| R01DC014678 | Plasticity during visual/vestibular conflict | 1 | 2020 |
| R01DK049302 | Effect of Mineralocorticoid Receptor Blockade on Coronary Vasculature and Myocardial Structure in HIV | 1 | 2020 |
| R01DK074720 | Novel mechanisms involving complement cascade in stem cell trafficking | 1 | 2020 |
| R01DK107502 | Mechanisms of genetic risk at 2p23 in Eosinophilic Esophagitis | 1 | 2020 |
| R01ES025214 | Early life perfluoroalkyl substance exposure & obesity: Mechanisms & phenotyping | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4591/grants?page=21